- Human Monoclonal Antibody Inhibiting Reverse Transcriptase Activity of Hepatitis B Virus Polymerase Protein
-
Park SJ, Seol SY, Jee SR, Park ET, Lee YJ, Lee SH, Chung JM, Cho HD, Jeong YJ, Choi IH, Park SG
- KMID: 935184
- Korean J Gastroenterol.
- 2007 Feb;49(2):85-92.
BACKGROUND/AIMS: To develop a novel treatment method for hepatitis B virus (HBV) infection, we aimed to make a human monoclonal antibody inhibiting reverse transcriptase (RT) activity of P protein which... -
- CITED
-
- Close
- SHARE
-
- Close
- Genotypic resistance to entecavir in chronic hepatitis B patients
-
Kim BU, Goo JC, Park BC, Kim SO, Hong SP, Jeong JI, Chae HB, Park SM, Youn SJ
- KMID: 1792593
- Korean J Hepatol.
- 2010 Jun;16(2):147-157.
- doi: 10.3350/kjhep.2010.16.2.147
BACKGROUND/AIMS: The prevalence and clinical characteristics of entecavir (ETV) resistance is not well known. The aim of this study was to determine the frequency of genotypic resistance in nonresponders and... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term clevudine therapy in nucleos(t)ide-naive and lamivudine-experienced patients with hepatitis B virus-related chronic liver diseases
-
Lee HJ, Eun JR, Lee CH, Hwang JS, Suh JI, Kim BS, Jang BK
- KMID: 1381439
- Korean J Hepatol.
- 2009 Jun;15(2):179-192.
- doi: 10.3350/kjhep.2009.15.2.179
BACKGROUNDS/AIMS: Clevudine is an effective antiviral nucleoside analogue, but there are few data regarding its long-term effects, resistance, and safety. The aim of this study was to evaluate the long-term... -
- CITED
-
- Close
- SHARE
-
- Close
